Cost effectiveness of tiotropium for chronic obstructive pulmonary disease: a systematic review of the evidence

  • Mauskopf J
  • Baker C
  • Monz B
 et al. 
  • 5


    Mendeley users who have this article in their library.
  • 14


    Citations of this article.


Tiotropium has been shown to reduce exacerbations and improve quality of life for patients with chronic obstructive pulmonary disease (COPD), a lung disease characterized by a persistent and progressive airflow limitation.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


  • Josephine A. Mauskopf

  • Christine L. Baker

  • Brigitta U. Monz

  • Melissa D. Juniper

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free